MAXHEALTH Max Healthcare Institute Q3 FY26 results (Oct–Dec 2025) and concall
Management summary
- Max Healthcare delivered its 21st consecutive quarter of YoY growth despite seasonal softness and temporary disruptions from insurance cashless services and regulatory changes.
- The company continued aggressive expansion with new bed additions and geographic diversification into Western India.
Source: Inve concall analysis and management guidance record.
What they filed
Q3 FY26: revenue up 10.7%, net profit up 25.9% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|
| Revenue | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 +11% |
| EBITDA | 499 | 512 | 523 | 575 | 538 +8% |
| Net profit | 239 | 319 | 308 | 491 | 301 +26% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Guidance & targets
2Expansion
Pune Hospital Expansion · By 2030 · High confidence 450 beds
Capacity
Max Dwarka Expansion Capacity · Near-term · High confidence Additional 260 beds
Source: Inve Guidance Tracker — management targets and direct quotes from the earnings call transcript.
Unlock risks & concerns, Q4 FY26 watchlist, and full call analysis
You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:
- 3 risks, concerns & management red flags
- Watchlist triggers for Q4 FY26
- +1 more guidance target & verbatim management quotes
- Full section-by-section call narrative
Sign in to use your monthly call allowance.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image





